0
Editorials |

Topical Hemostatic Tamponade: Another Tool in the Treatment of Massive Hemoptysis

George Reisz, MD, FCCP
Author and Funding Information

Affiliations: Kansas City, MO
 ,  Dr. Reisz is Edward H. Hashinger Distinguished Professor and Chairman, Department of Medicine, University of Missouri Kansas City School of Medicine, and Truman Medical Center.

Correspondence to: George Reisz, MD, FCCP, Department of Medicine, Office of the Chair, University of Missouri Kansas City School of Medicine, 2301 Holmes St, Kansas City, MO 64108; e-mail: reiszg@umkc.edu



Chest. 2005;127(6):1888-1889. doi:10.1378/chest.127.6.1888
Text Size: A A A
Published online

Extract

Hemoptysis is not a separate disease; rather it is a manifestation of multiple pathologic processes. Despite the potentially fatal outcome of hemoptysis, the underlying disease is usually otherwise benign and treatable.13 The risk of death is particularly high when hemoptysis is massive, and some investigators46 estimate the risk of mortality with untreated massive hemoptysis to be in excess of 75%. Others78 have found the risk of death to be lower and have advocated an initially conservative approach, although there may be significant mortality from subsequent bouts of hemoptysis in these patients. Some of the variation in mortality risk is due to the lack of the common definition of the term massive. However it is defined, it is clear that massive hemoptysis represents a significant and immediate risk to these patients.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543